Hint mode is switched on Switch off

Reviva Pharmaceuticals, ordinary share
RVPH, US76152G2093

Add a stock to WL
Choose all Reset all
Reviva Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Reviva Pharmaceuticals Inc (formerly Tenzing Acquisition Corp) intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage ...
Reviva Pharmaceuticals Inc (formerly Tenzing Acquisition Corp) intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage in any other similar business combination with one or more businesses or entities.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Reviva Pharmaceuticals Inc (formerly Tenzing Acquisition Corp)
  • Industry
    Pharmaceutical Preparation and Biotechnology

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
III q eng
IV q eng
Show all Hide

Indicators

News

15/04/2026 Reviva Pharmaceuticals: , Including The Information Contained In Exhibit 99.1, Is Being Furnished To The Securities And Exchange Commission, And Shall Not Be Deemed To Be “filed” For The Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, And Shall Not Be Deemed To Be Incorporated By Reference Into Any Filing Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Shall Be Expressly Set Forth By A Specific Reference In Such Filing
04/03/2026 Reviva Pharmaceuticals: Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
20/01/2026 Reviva Pharmaceuticals: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard, Other Events
18/12/2025 Reviva Pharmaceuticals: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
24/10/2025 Comparative Analysis of Biopharmaceutical Companies on NASDAQ
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.